Progesterone resistance in endometriosis: origins, consequences and interventions (Q39250801)

10 September 2017

Progesterone resistance in endometriosis: origins, consequences and interventions (English)

1 reference

10 September 2017

1 reference

progesterone resistance

1 reference

Bansari G Patel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28423456%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Jie Yu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28423456%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Yimin Shu

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28423456%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

19 April 2017

1 reference

Acta Obstetricia et Gynecologica Scandinavica

10 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28423456%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28423456%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28423456%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

623-632

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28423456%20AND%20SRC:MED&resulttype=core&format=json

Role of nuclear progesterone receptor isoforms in uterine pathophysiology

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Eutopic endometrium in women with endometriosis: ground zero for the study of implantation defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Reduced connexin 43 in eutopic endometrium and cultured endometrial stromal cells from subjects with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Physiopathological aspects of corpus luteum defect in infertile patients with mild/minimal endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Luteal function in infertile patients with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Potential role of endometrial stem/progenitor cells in the pathogenesis of early-onset endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

The endometrium from the neonate to the adolescent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Embryologic origin of endometriosis: analysis of 101 human female fetuses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Low birth weight is strongly associated with the risk of deep infiltrating endometriosis: results of a 743 case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

In utero exposures and the incidence of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Mechanisms of endometrial progesterone resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Prolonged stimulation with tumor necrosis factor-alpha induced partial methylation at PR-B promoter in immortalized epithelial-like endometriotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

The progesterone receptor coactivator Hic-5 is involved in the pathophysiology of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Dioxin and endometrial progesterone resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Endocrine effects of prenatal exposure to PCBs, dioxins, and other xenobiotics: implications for policy and future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Dioxin stimulates RANTES expression in an in-vitro model of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Progesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

The Role of Endocrine Disruptors in the Epigenetics of Reproductive Disease and Dysfunction: Potential Relevance to Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Human Endometrial Fibroblasts Derived from Mesenchymal Progenitors Inherit Progesterone Resistance and Acquire an Inflammatory Phenotype in the Endometrial Niche in Endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Genetics of endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Identifying the biological basis of GWAS hits for endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

PROGINS receptor gene polymorphism is associated with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Epigenetics of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

The knockdown of progesterone receptor isoform B (PR-B) promotes proliferation in immortalized endometrial stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

miR-196a overexpression activates the MEK/ERK signal and represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Altered retinoid uptake and action contributes to cell survival in endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Fenretinide: A Potential Treatment for Endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Postoperative oral contraceptive exposure and risk of endometrioma recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Progestins for symptomatic endometriosis: a critical analysis of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

The use of newer progestins for contraception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Dienogest: a new therapeutic agent for the treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Changes in quality of life after hormonal treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Endometriosis: current and future medical therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Partial suppression of estradiol: a new strategy in endometriosis management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Aromatase inhibitors for the treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

Intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAOGS.13156

21 January 2018

Identifiers

DOI

10.1111/AOGS.13156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28423456%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference